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The B receptor has a molecular weight of about 130 kD, exhibits a high affinity to circulating ANF and is considered to mediate the biological actions of ANF by activating particulate guanylate cyclase, which is part of its intracellular domain. It has thus been called "B" (for biologically active) receptor. The difference in structural requirements for binding of ANF ligands allows for quantitative discrimination from the B receptor. This binding site removes ANF from the circulation without inducing apparent biological actions and has thus been termed "C" (for clearance) receptor. The C receptor has a molecular weight of about 65 kD, binds circulating ANF with lower affinity but also binds truncated analogs of ANF.
Alterations of total glomerular ANF receptor density have been demonstrated after changes of body fluid volume (10) (11) (12) . Recently, we have shown that physiological changes of body fluid volume affect density of both receptor subtypes on glomerular membranes to a different extent (13) . Therefore it is important to discriminate between B and C receptors also when investigating the ANF receptor status in a pathophysiological state.
Renal response to ANF has been shown to be blunted in patients with cirrhosis and in rat models of cirrhosis (14) (15) (16) (17) (18) (19) (20) (21) . This renal resistance to circulating and to exogenously administered ANF in cirrhosis might be due to an alteration of ANF receptor density. Therefore in this study we investigated both types of ANF binding sites in renal glomeruli of cirrhotic rats.
MATERIALS AND METHODS
Animals. Male Sprague-Dawley rats (300 to 320 g m ) were subjected to bile duct ligation and division (22). In the control group, animals were sham-operated with visualization of the bile duct. The rats were fed with regular pelleted chow and tap 563 water. Approximately 6 wk after bile duct ligation, rats with evidence of ascites were decapitated, trunk blood was collected in precooled EDTA tubes (1 mg/ml) and the kidneys were rapidly excised. Ten bile duct-ligated (BDL) animals with ascites were compared with 10 sham-operated controls (SHAM).
RLA for ANF. Blood samples were centrifuged at 1,500 g for 10 min at 4" C and the plasma was stored at -70" C until assay. Extraction of plasma samples and RIA procedures were modified from previously reported procedures (17, 23) . Briefly, 200 ~1 plasma samples were extracted by adsorption to activated Amberlite XAD-2 adsorbent resin (particle size 0.3 to 1.0 mm, Serva, Heidelberg, FRG) and eluted with acetonitrile/O.l% trifluoroacetic acid (80%/20%). Recovery was 70% and the detection limit of the RIA was 0.5 f m o h b e .
Preparation of Glomerular Membranes. Rat glomeruli were isolated according to a graded sieving method (24) with some modifications. Kidneys were cut longitudinally, the medulla was removed and the cortical tissue was filtered through 250 pm, 140 pm and 75 pm sieves. Glomeruli were then suspended in ice-cold PBS, pH 7.5, and centrifuged (10,000 g, 4" C, 10 rnin). Membranes were prepared by resuspending the glomeruli in 50 mmol/L Tris-HC1, pH 7.4, 1 mmol/L NaHCO, and by homogenizing with a Polytron (Kinematica, Littau, Switzerland) at 4" C, setting 6 for 3 x 20 sec. Binding h a y . Binding studies were performed in triplicate at 4" C for 5 hr in a HEPES buffer, as described elsewhere (13, 26) . Incubation volume was 0. After incubation, the membranes were washed, resuspended in ice-cold PBS buffer, pH 7.5, and incubated with 0.1 mmol/L bis(sulfosuccinimidy1)suberate (Pierce, Beijerland, The Netherlands) for 25 min at 4" C. The reaction was quenched by adding 10 mmol/L ammonium acetate and the membranes were centrifuged in an Eppendorf centrifuge for 7 min. The pellet was resuspended in 30 pl sample buffer (62 mmoVL Tris-HC1, pH 6.8, 2% SDS, 10% glycerol, 0.001% bromphenol blue) containing 5% 2-mercaptoethanol and heated for 3 min at 100" C. Membrane proteins were separated on a 7.5% SDS-PAGE under constant voltage conditions (Hoefer Scientific Instruments, San Francisco, CA). Standard molecular weight markers were used for calculation of molecular weights (Fig. 1, upper panel) (Fig. 1, lower panel) showed a monophasic curve, displacing less of the labeled peptide at excess concentrations than rANF(99-126). Thus there were probably B and C receptors present on glomerular membranes, with the majority of the C type. Analysis of competition binding curves t o glomerular membranes (Fig. 1) showed that the total receptor density was significantly increased (3,518 ? 864 vs. and in BDL rats. Autoradiography of the dried gel of glomerular membrane preparations from both BDL rats and controls showed two bands with the apparent molecular weights of 65 kD, as reported for the C receptor, and 130 kD, as demonstrated for the B receptor ( Fig. 2A) . Displacement with increasing concentrations of unlabeled ANF proved the specificity of lZ5I-rANF cross-linking (Fig. 2B) . Excess concentrations (10 -6 mol/L) of the truncated analogue, binding to the C receptor only, displaced the band at 65 kD but not the band at 130 kD (Fig. 2C) .
Thus the two ANF binding sites determined under our experimental conditions were most likely identified as B and C receptors.
DISCUSSION
In this study, we found an altered density of ANF binding sites on renal glomeruli of cirrhotic rats. Bile 
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duct ligation was chosen as a rat model of cirrhosis; to assure an advanced stage with massive sodium retention, only animals with marked ascites were investigated.
The two types of ANF binding sites, identified on glomerular membranes, most likely correspond to the B and C receptors. This conclusion is supported by the following observations: (a) Competitive binding curves with the unlabeled ligand ANF(99-126), binding to both receptors, exhibited a biphasic shape and computerized analysis continuously yielded better fits for two than for one binding site. Furthermore, displacement with the truncated analogue, binding to C receptors only, showed just one class of receptors (Fig. 1). (b) Resolutions of glomerular membranes by SDS-PAGE after crosslinking to 12"I-rANF showed two specifically labeled bands at 65 kD and 130 kD, corresponding to the reported molecular weight of the C and B receptor, respectively, with the truncated analogue displacing the 65 kD band only (Fig. 2) .
The density of total ANF binding sites was markedly increased in BDL rats compared with controls. These findings are in accordance with the observation of increased glomerular ANF receptor density in BDL rats by Morgan et al. (28) . These authors, however, while finding a blunted cGMP generation, did not differentiate ANF receptor types. Discrimination of both ANF receptors showed that the increased receptor density in our experiments was due to a twofold augmented number of C receptors. B-receptor density was not significantly decreased in BDL rats. The ratio of B to C receptors was eminently reduced in BDL animals. Thus a given dose of ANF would be less effective in the kidney of cirrhotic compared with control animals: the proportion of ANF reaching the B receptors would be reduced; moreover, the number of B receptors, linking ANF to its biological effects, tended to be decreased.
Because the changes of density of ANF receptors in cirrhosis were accompanied by a tendency of inverse alterations of affinity, there might be doubts about the biological net result of these changes. However, several observations are against such an interpretation: Reciprocal changes of binding capacity and affinity of ANF to glomeruli have often been described (11, 12, 29) (e.g., a 3.5-fold increase of receptor density after a low salt diet accompanied by a 2.5-fold decrease of affinity) (10) . Contrary to the hypothesis that this lowering of the affinity would tend to oppose the augmented receptor density, greater ANF binding was observed in this group of animals at any given ANF concentration (10) . Thus, it seems that changes in receptor density outweigh changes in affinity. Furthermore, to eliminate possible influences of affinity on the calculated receptor density, we additionally performed a simultaneous fit of the binding data of both groups and calculations with the same, shared affinity for all animals with the LIGAND program (27) . Both approaches yielded similar results as those generated by individual fits shown in Table 1 . Thus using various analytical procedures, C-receptor density was constantly found to be significantly augmented in cirrhosis.
Why was glomerular density of ANF receptors changed in the cirrhotic rats? Because little information is available on the regulation of B and C receptors for ANF by physiological stimuli and this is the first communication about the influence of a pathophysiological condition on the ANF receptor status, the question can hardly be answered. Increased density of glomerular ANF binding sites has been observed on dehydration or low salt diet (10) (11) (12) . We could recently demonstrate that dehydration selectively increases C receptors with no effect on B-receptor density (13) . This change was accompanied by a decrease of ANF plasma concentration. In the present investigation, however, cirrhotic rats exhibited increased C-receptor density at ANF plasma concentrations not different from those of control rats. Therefore changes of ANF receptor density in the BDL animals cannot be explained by different concentrations of circulating ANF. Thus expression of glomerular ANF receptors is altered in cirrhosis by a mechanism that remains to be elucidated.
Actually, renal response to endogenously released and to exogenously administered ANF is blunted in cirrhosis (for review see references 30 and 31). Several factors, such as a decrease of blood pressure or an activation of sodium-retaining systems after the administration of ANF, might be involved therein (18,20,32) . However, as demonstrated by our study, alterations of renal ANF receptor density might also contribute to the renal resistance to ANF. The present investigation, for the first time quantitatively determining renal B and C receptors for ANF in a pathophysiological state, shows an increased number of clearance receptors in the BDL model of cirrhosis. Thus alterations of renal ANF binding sites indeed could contribute to the observed resistance to ANF in cirrhosis. 
